Webcast | November 2020 - CNS Pharmaceuticals

CNS Pharmaceuticals’ Webinar – November 2020

Disclaimer: The views and opinions expressed by Robert LeBoyer, Managing Director of Equity Research, Ladenburg Thalmann & Co., Inc., are those of Mr. LeBoyer exclusively and do not necessarily reflect the views or opinions of CNS Pharmaceuticals, Inc. (the ‘Company”). The Company is not responsible for such views or opinions and can offer no assurance that actual performance and events will not differ from such views and opinions.

Join Our Newsletter To Follow Our Progress!

First Name*
Email*
Cell (Used For Press Releases)
Click to See Terms of Service.
Click to See Privacy Policy.
Messages and data rates may apply. Reply STOP to end or HELP for help.
Terms and Conditions*
- You consent to us contacting you using all channels of communication and for all purposes, using all contact information you provide to us. You also consent to us and our successors (if any), using email, text messages, any automatic telephone dialing system and/or an artificial or prerecorded voice when contacting you, even if you are charged for the text message or call under your phone plan. You are responsible for any charges for contacting you that may be billed to you by your communications carriers.